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ABSTRACT 
 
 
Purpose 
Detection of adenomas is the foundation of colorectal cancer screening utilizing 
screening colonoscopies. Adenoma detection rate (ADR) is an increasingly utilized core 
quality measure for colonoscopies. Colonoscopy is an effective tool to prevent colon 
cancer but missed lesions can lead to development of interval colon cancer. These missed 
lesions are particularly in right-side of the colon. Careful examination of the right colon 
is recommended but the ideal withdrawal time for the right colon is unknown. 
Design /Method 
We conducted a prospective, randomized controlled trial in patients undergoing screening 
or surveillance colonoscopies for colorectal cancer at three hospitals. Adenoma detection 
rate was defined as the proportion of colonoscopies in which adenomas were detected, 
compared to all colonoscopies. ADR was compared in patients with < 3mins right colon 
(up to hepatic flexure) withdrawal time, to patients with ≥ 3mins right colon withdrawal 
time. Time spent from identifying the appendiceal orifice till the start of withdrawal, 
which included time spent intubating the terminal ileum and examining the ileum, was 
excluded as this time is usually not used to identify polyps. A secondary end point was to 
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observe if retroflexion for ≥ 30 seconds compared to < 30 seconds improved ADR in the 
right colon. 
Results 
A total of 250 patients after randomization were included in the analysis. This 
sample included 135 patients in the < 3 minute right colon withdrawal group (RCWG) 
and 115 patients included in the ≥3 minute RCWG. Adenoma detection rate in the right 
colon was 33% if the right colon withdrawal time was ≥3mins compared to 14% if it was 
< 3 mins; the likelihood of finding right-sided adenomas was 3 times greater in the ≥ 3 
min group compared to the < 3 min group, (OR 3, p<0.001, 95% CI 1.62-5.64). The 
adenoma detection rate in the right colon was also significantly higher when the modified 
right colon withdrawal time was used in ≥ 3mins group  vs. < 3mins group which also 
showed that the ≥ 3mins group was 3 times more likely to find adenomas in the right  
colon compared to the < 3 min group (OR 3, p<0.001, 95% CI 1.62-5.64).Adenoma 
detection rate in the right colon was 45% when retroflexion was performed for≥ 30 
seconds compared to 23% in the group where it was performed for < 30 seconds (OR 2.8, 
p=0.01, 95% CI 1.26 – 6.0). Polyps that were seen only on retroflexion, which could not 
be seen on forward view, were significantly more likely to be found in the ≥ 30 second 
group (22%, n =8) compared to the < 30 second group 3%, p<0.001.  
Conclusion 
Adenoma detection rate in the right colon was significantly higher when three 
minutes or more were spent examining the right colon during withdrawal. Significantly 
higher rates were seen even after taking polypectomy into account and in the average risk 
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screening population. Adenoma detection rate in the right colon was also significantly 
improved when retroflexion wasperformed for more than 30 seconds. 
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CHAPTER 1 
INTRODUCTION 
 
Colorectal cancer (CRC) is the second leading cause of cancer related death in the 
United States.1Colonoscopy is consideredthe test of choice for screening for colon 
cancer2,3with the objective to reduce incidence and mortality from colorectal cancer.4The 
incidence of colorectal cancer has been shown to have progressively decreased in the 
United States since screening recommendations for colorectal cancer were first 
introduced in the 1970’s. Adenomas are precursor lesions that can predict the risk of 
CRC, and removal of adenomatouspolyps can reduce the occurrence of CRC by over 
50%.2,5 Therefore removal of precursor lesions can lead to prevention of colon cancer or 
detection at an early stage.4,6Adenoma detection rate (ADR) is an increasingly utilized 
core quality measure for colonoscopies.3United States has achieved the highest rates 
compared to other countries of adherence to screening recommendations of 
60%.6However, missed rate of adenomas can be as high as 30%;2,5colonoscopies provide 
inadequate protection from right-sided colon cancer in particular.4,7,8In a large study at 13 
centers in the United States, there were large variations (from 7.4% to 52.5%) found in 
adenoma detection rates among 136 gastroenterologists.1 Each 1% increase in ADR was 
associated with 3% decreased risk of cancer; a 5% decrease in colorectal cancer death 
and adjusted hazard ratio was 0.52 (95% CI 0.39 to 0.69) was found when endoscopists 
from the highest quintile were compared to the endoscopists in the lowest quintile of 
ADR.1 
The right side of the colon can be difficult to evaluate fully due to technical 
difficulty and maneuverability. A colonoscopy can provide a reduction in incidence and 
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mortality from colon cancer by 80% in the left colon but only 40-60% in the right 
colon.4,9,10Therefore, there is emphasis on improved examination of the right side of the 
colon but data are lacking on tools and techniques that can help improve the adenoma 
detection rate on the right side. 
Withdrawal time is the time spent examining the colon during the screening 
process and is usually the time from identifying the appendicealorificeuntil the 
withdrawal of the colonoscopeto complete the exam. Some centers define withdrawal 
time as the time from examining the terminal ileum until the end of the exam, as 
occasionally intubating the terminal ileum can be challenging and this time is not spent 
examining the colon. A withdrawal time of at least six minutes has been shown to 
improve adenoma detection rate, but the ideal withdrawal time for the right side of the 
colon is unknown. Retroflexion in the ascending colon has been shown to improve 
adenoma detection rate,11but the optimal time for examining the right side of the colon 
during retroflexion is also unknown.  
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CHAPTER 2 
REVIEW OF LITERATURE 
 
Background 
Colon cancer is a leading cause of cancer death in males and females.1Colon cancer also 
creates a significant burden on the health care system. Colonoscopy has been shown to be 
an effective tool in decreasing the disease burden and improving mortality.4 Adenomas 
are precursors to colon cancer in about 70% of colon cancer cases,12 and the goal of 
screening is to remove adenomas and either prevent colon cancer or to detect lesions at 
an earlier stage. Colonic lesions on the right side of the colon have a significantly higher 
risk of being missed which is attributed at least in part to technical difficulty and colonic 
folds.4,9,13 
 
Epidemiology 
Risk of colon cancer increases with age and incidence varies in different parts of 
the world.  According to the GLOBOCAN statistics, which estimate global cancer 
incidence and mortality, colorectal cancer accounts for about 1.31 million new cases per 
year worldwide and about 694,000 deaths per year. Colorectal cancer is more common in 
men compared to women and risk is also higher in African Americans compared to other 
race/ethnic groups. In the United States, it accounts for 134,000 cases per year and about 
55,000 cancer deaths. The incidence and mortality from colon cancer worldwide is 
increasing whereas in the United States has decreased by 2.5-4% per year over the past 
15 years.13 
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There has been a decrease in incidence in the United States with the incidence 
reduced from 87.3/100,000 cases in 1975-1979 to 53.2/100,000 cases in 2010-
2013.14Colorectal cancer is higher after the ages of 40-50 years which explains why 
screening guidelines recommend global screening above the age of 50. The incidence in 
the population under the age of 50, however, has been increasing.14,15 Left sided colon 
cancers are more common than right sided cancers, but there has been a trend towards 
increasing number of right sided colon cancers more recently.16 
 
Pathogenesis 
Colorectal cancer most commonly arises from benign polyps in the colonic 
mucosa which develop into cancer over a period of many years. Adenomas precede colon 
cancer in 70% of cases.12Tubulovillous adenomas and sessile serrated polyps can also 
precede colon cancer development. Hyperplastic polyps are type of polyps that are 
largely not thought to progress to colon cancer. An adenoma takes more than 10 years to 
transform into a cancerous lesion4 but can be earlier in familial cancer disorders. 
Therefore, a colonoscopy is recommended every 10 years in the average risk 
population;the screening interval is shortened if there is family history of colon cancer, 
personal history of colon polyps or the patient has a familial cancer disorder.  
Various factors play a role in the adenoma to carcinoma sequence and include 
gene mutations, epigenetic alterations and local inflammatory changes.17 Traditional 
tubular adenomas are initiated either after biallelic inactivation of the Adenomatous 
Polyposis Coli (APC) tumor-suppressor gene or by chromosome instability which in turn 
leads to gain and loss of genes, parts of a chromosome or whole chromosomes.17 Sessile 
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serrated polyps are associated with CIMP (CpG Island Methylator Phenotype). Other 
genomic instabilities responsible for transformation of colonic epithelium to pre-
cancerous or cancerous lesions are chromosomal instability, microsatellite instability, 
non-microsatellite instability, hypermutability,aberrant DNA methylation and global 
DNA hypomethylation.17,18 
Chromosomal instability is the gain of one or more chromosomes or multiple 
structural abnormalities; itaccounts for about 85% of all colorectal cancers.18 Polyposis 
syndromes carry a high risk of colorectal cancer and these syndromes have specific gene 
involvement. Familial adenomatous polyposis syndrome (FAP) carries a nearly 100% 
risk of cancer in affected individuals, and average age of symptoms is at 16 years of age. 
APC gene, which is on chromosome 5, is also involved. Patients affected by this FAP 
require a total colectomy at a young age when the first polyp is found.  
Attenuated FAP is a variant of FAP which also affects chromosome 5, but the site 
of mutation is different from the APC site. Lynch syndrome is more common than FAP, 
and the genes affected are the mismatch repair genes (i.e., hMLH1, or hPMS2, hMSH2 or 
hMSH6). Lynchsyndrome is autosomal recessive compared to FAP which is autosomal 
dominant. Lynchsyndrome causes adenomas in the right side of the colon more 
commonly, and risk of colorectal cancer is highest in middle age (30-39 years) and 
decreases thereafter.19  MUTYH (mutY homolog) associated polyposis is an autosomal 
recessive disorder caused by mutation in the MUTYH gene which is a base excision 
repair gene that can damage the APC gene.Colorectal cancer risk is also higher in 
patients with long standing inflammatory bowel disease, previous abdominal radiation, 
transplant patients, obesity, red meat where a high fiber diet can be protective.   
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Clinical Presentation, Diagnosis and Staging 
 
A high index of suspicion is needed for early diagnosis of colon cancer as the 
clinical presentation can be variable and subtle. Early diagnosis can be made when 
patients get a screening colonoscopy.4,6Fecal-based screening tests, imaging studies for 
screening and other endoscopic approaches as discussed previously can also lead to early 
detection. Patients diagnosed during screening procedures are often asymptomatic at the 
time of diagnosis. However, the majority of patients (86%) under the age of 50 years who 
are diagnosed are likely to be symptomatic at the time of diagnosis and have worse 
outcomes due to the typical later stage of disease at diagnosis.20 Patients can also present 
with iron deficiency anemia from chronic blood loss from the tumor. Presentation with 
intestinal obstruction or an acute GI bleeding is also encountered. Symptoms from 
unchecked growth of the cancer can lead to constipation and large bowel obstruction. 
Right sided lesions are more likely to present as iron deficiency anemia while left sided 
lesions are more likely to present with obstruction and malignant strictures. Patients 
presenting with obstruction can also present with abdominal pain, nausea and vomiting. 
Patients with more distal lesions, especially in the rectum, present with hematochezia. 
 If the disease is diagnosed late, patients can present with symptoms resulting from 
metastatic spread. This can include liver abnormalities, lung nodules, bony lesions or 
peritoneal lesions. These patients can also present with jaundice, shortness of air, bone 
pain or abdominal pain. 
 Diagnosis is usually made by colonoscopy or cross-sectional imaging. Even when 
imaging shows characteristic features of colon cancer, a colonoscopy is still usually 
pursued for tissue acquisition. A colonoscopy can also diagnose synchronous or meta-
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synchronous lesions. If a patient is a candidate for resection, a colonoscopy can also 
localize the extent of the tumor, mark the sites of resection with tattoos and removeother 
polyps. Often times a malignant lesion will have a characteristic appearance but 
pathology is always obtained when possible. If a colonoscopy is unable to be completed, 
a double contrast barium enema, CT colonography or a colonic capsule can be used. 
Tumor markers including carcinoembryonic antigen (CEA) and carbohydrate antigen 19-
9 (CA 19-9) can aid in diagnosis, but they have low sensitivity.21 If advanced disease is 
suspected, a CT chest, abdomen and pelvis must be obtained for staging. 
 The TNM staging system is the most widely used and it classifies disease from 
Stage 0 to stage IV(see table on page 31that is takenfrom emedicien.medscape.com). T in 
the staging system indicates the primary tumor, N describes involvement of regional 
lymph nodes and M identifies presence or absence of distant metastasis.  
Management 
 
Management is directed by stage of the cancer. Signs and symptoms along with 
the cancer stage are also taken into account when directing a management strategy.  
 Larger polyps are more likely to have malignant potential compared to smaller 
adenomas of <5mm.22When the disease is localized to the mucosa or at a focal point 
within a polyp (carcinoma in situ), endoscopic resection can be curative in some cases 
especially when the resection margins are cancer free. Endoscopic submucosal dissection 
(ESD) or endoscopic mucosal resection (EMR) can be used to remove large polyps and 
lesions amendable to endoscopic resection.  Surgical resection is more commonly used 
for resection of the involved segment and regional lymph nodes. Surgery can result in a 
colo-colonic or anileo-colonic anastomosis, or it can lead to a temporary or permanent 
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colostomy depending on the location of the cancer, stage and local involvement. When 
there is wide spread metastasis, surgical management may be pursued if there are signs of 
bowel obstruction or bleeding from the cancer. When patients present with colonic 
obstruction from colon cancer, a colonic stent placed endoscopically is a reasonable 
approach in select patients, especially in patients who are not good surgical candidates.  
Risks and benefits should be discussed thoroughly with the patient and family before a 
treatment plan is made.  
 The role of adjuvant chemotherapy is most studied in stage III with lymph node 
positive disease where chemotherapy after surgical resection has been shown to reduce 
recurrence by targeting micrometastases and reducing mortality by 22-32%. 
Chemotherapy is not used in stage I disease and is controversial in stage II disease. The 
most commonly used chemotherapeutic options are 5 fluorouracil and oxaliplatin, and the 
most commonly used preparation is FOLFOX (oxaliplatin, 5FU and leucovorin). The role 
of radiation therapy in patients with colon cancer is usually limited to patients with rectal 
cancer especially at advanced stages. 
 According to data from the American Cancer Society, 5 year survival of patients 
with stage I colon cancer is 92% compared to only 11% at stage IV. Rectal cancers also 
have similar prognosis.  This emphasizes the importance of early detection and 
management.  
 
Adenoma Detection Rate in Colonoscopies 
 
Colonoscopy is an effective tool for reducing the burden of colorectal cancer and 
reducing mortality.4Polypectomy (complete removal of a polyp)during colonoscopy is the 
most effective intervention for preventing colorectal cancer.14The 10 year colon cancer 
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related death rate decreased by 53% when patients undergoing colonoscopy and 
polypectomy were compared to the general population in a large case control 
study.6Adenoma detection rate is the benchmark for measuring the quality of endoscopy. 
Adenoma detection rate is the proportion of adenomas or adenocarcinomas found by an 
endoscopist while performing screening colonoscopies for colorectal cancer. It is 
inversely related to risk of interval colorectal cancer and fatal interval cancer.1Missed 
lesions are more common in the right side of the colon.4,7Non-polypoid lesions are also a 
concern as they are more difficult to detect due to visual difficulties differentiating them 
from surrounding mucosa; these lesionscan have a prevalence of 9.3% as studied in 1819 
patients undergoing routine colonoscopy.23 
An adenoma detection rate target was first proposed by the United States Multi-
Society Task Force on Colorectal Cancer, in 2002, as a standard for quality endoscopy.24 
Adenoma detection rates of 25% for men and 15% for women were proposed. These 
standards have been adjusted to 30% for men and 25% for women in the 2015 ACG and 
ASGE quality indicator update.25 Several interventions have been shown to be effective 
in improving adenoma detection rate. In one study, intervention in the form of two 1-hour 
sessions focusing on endoscopic technique and appearance of lesions significantly 
improved ADR .26Higher adenoma detection rates have been seen when an experienced 
nurse is present as a second observer in addition to the endoscopist.27 Similarly higher 
adenoma detection rates have been shown with fellow (trainee) involvement during 
colonoscopy.28 
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Withdrawal Technique and Adenoma Detection Rate 
Withdrawal time has been shown to be closely associated with adenoma detection 
rate. This association is positivelyrelated as spending more time examining the mucosa 
during screening colonoscopy can increase adenoma detection rate.25,29,30Barcley et al 
first found a linear positive correlation between mean withdrawal time and adenoma 
detection rate.29Withdrawal time of 6 minutes has been postulated as a quality measure 
for screening colonoscopy.25In another study, a withdrawal time longer than 8 minutes 
was associated with an even higher rate of adenoma detection.30 However,there are 
currently no guidelines available to specify time spent with respect to each part of colon. 
Klare et al. showed a significant association between observation time in the proximal 
colon and detection of adenomas31 and concluded that the minimum time required for 
sufficient adenoma detection in the proximal colon is 4 min 7 sec. This population was 
undergoing colonoscopies for various indications and not only for screening for 
colorectal cancer. In one study with 850 patients undergoing a screening or surveillance 
colonoscopy, a second examination of the right side of the colon in either forward view 
or retroflexed view improved ADR as more lesions were found on a second exam. 
Second forward view compared to retroflexed second view was comparable.2 Split dose 
bowel preparation has also been shown to improve adenoma detection rate compared to 
standard preparations.30 
Retroflexion in the Right Colon 
 
Retroflexion in the right colon has been shown to improve visualization  behind 
folds/flexure during theretroflexionmaneuver.11The success of retroflexionin detecting 
adenomas can range between 79.5% to 95.9% and is operator dependent.32 Various 
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reasons for failure of retroflexionhave been proposed, including, but not limited to, 
anatomical restrictions/small right colon diameter, multiple co-morbidities, severe 
diverticulosis, abdominal pain, time constraints, failed retroflexion despite 2 trials, 
excessive instrumental looping, restricted mobility of the colon, equipment 
malfunctioning, poor bowel prep and experience of operator.2,5,33Retroflexion in the 
rectum is standard practice and has shown to improve adenoma detection rate;in one 
study, 50% of lesions in the anorectum were identified only on retroflexion.34 
Earlier studies did not show significant differences in adenoma missed rate when 
retroflexion was compared with second examination of right colon with forward 
view.2,35,36  However recent studies by Lee et al.5 and Chandran et al.11 have 
demonstrated increased adenoma detection, especially small sized (<5mm) polyps in the 
cecum and ascending colon with the help of retroflexion. One meta-analysis3 revealed 
that retroflexed view detects approximately 17% of right sided adenomas that would have 
been missed with standard single forward view. Pishavanet al.37 also showed the value of 
use of retroflexion for the resection of sessile polyps that were difficult to access by 
standard view alone. Yield of right colon adenomas is significantly increased when 
patient has a history of colon polyps, age equal to or greater than 55 years, poor quality 
impression during initial examination by endoscopistorfinding adenomas on the initial 
examination of the proximal colon.2,32Generally, the technique of retroflexion is 
considered safe.3,5,11,33,35Complications associated with the technique appear to be rare 
and no additional analgesia or sedation is required.38 There has been one case report 
demonstrating contained colonic perforation secondary to cecalretroflexion technique 
requiring conservative management. Incidence of major complications is similar in 
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comparison to those who are not exposed to cecal retroflexion.39Retroflexion attempt 
should be stopped if resistance is felt by the operator during bending or during 
advancement of scope to prevent complication.37 
Devices / Technology and Adenoma Detection Rate 
 
Many reasons have been postulated for low adenoma detection rate of proximal 
colon including difficulty in examining behind haustura, ileocecal valve, adenomas 
hidden behind proximal folds and inner aspect of hepatic flexures, and small flat polyps 
that are in the right side of colon.5,35,38 Use of high definition imaging during 
colonoscopy  significantly increases ADR and polyp detection rate compared to standard 
definition imaging.40 Blue laser imaging has been shown to be superior to standard 
colonoscopy in detecting adenomas in a large multicenter study.41Full spectrum 
endoscopy provides a 330 degrees view instead of conventional 140-170 degrees.42 This 
modality uses the forward tip as well as both sides of the tip which produces an image 
from each imager on a different screen. A multicenter study using this technique showed 
significantly lower adenoma miss rates when compared to standard colonoscopy (0% vs. 
17% respectively p=0.02).43 
Third Eye Retroscope, which is a retrograde viewing device, was shown to 
improve detection of adenomas when compared to standard colonoscopy. Adenoma miss 
rate was lower with Third Eye Colonoscopy (TEC) and the relative risk of missing polyps 
with standard colonoscopy was 2.56 compared to TEC.44 Withdrawal time, however, was 
longer by TEC by an average of one minute,and total procedure time was also longer by 
3 minutes. High definition chromoendoscopy has had mixed results compared to high 
definition white light endoscopy.45In addition, its use may not be justified in screening 
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colonoscopies as ittakes significantly longer than standard colonoscopy. Narrow Band 
Imaging (NBI) was also similar to conventional colonoscopy when comparing adenoma 
detection rates in a meta-analysis.46 
 Two other devices that can be attached on the endoscope are caps and cuffs. 
These help flatten folds during withdrawal and examine behind folds. Cuffs can be of 
different type but most commonly have flexible branches which also serve the same 
purpose as caps. Cap-assisted colonoscopy was shown in a meta-analysis to have similar 
adenoma detection rates when compared to conventional colonoscopy.47 Efficacy of cuff 
assisted colonoscopy was assessed in a randomized crossover trial of 274 patients who 
underwent cuff-assisted vs. standard colonoscopy. The cuff-assisted colonoscopy group 
had a higher ADR of 29.6% compared to 26.3% in the standard group, p=<0.01.48 
 
Adenoma detection rate has been linked to mortality and interval development of 
colon cancers and thus we sought to determine interventions to help improve this 
outcome measure. At the time of study initiation there was no published data to suggest 
an optimal time for examination of the right colon in forward view or during retroflexion. 
Given the implications of missed lesions and the need for improving adenoma detection 
rate, we conducted a multicenter, randomized controlled trial to investigate the benefit of 
spending three minutes or longer in the right side of the colon during withdrawal. 
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Our research questions were: 
1. Does spending three minutes or more in the right colon improve adenoma 
detection rate compared to spending less than three minutes? 
2. Does spending thirty seconds or more in retroflexion improve adenoma 
detection rate compared to spending less than thirty seconds? 
 
We hypothesized that spending three minutes or more in the right colon will 
improve adenoma detection rate compared to spending less than three minutes in the right 
colon. We also hypothesized that patients undergoing a longer period of retroflexion will 
have improved adenoma detection rate compared to patients undergoing retroflexion for a 
shorter duration. 
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CHAPTER 3 
METHODS AND MATERIALS 
Study Design, Data and Data Source 
We performed a multicenter, prospective, case-control study at three hospitals in 
the Saint Luke’s Health System Network. Data was collected from the electronic health 
record system at all hospitals as well as from patient encounters during their colonoscopy 
visit. Participating institutions were: 
1. Saint Luke’s Hospital of Kansas City Missouri 
2. Saint Luke’s North Hospital 
3. Saint Luke’s South Hospital 
All data was filled in by nursing staff and by study investigators. Demographic 
information including age, sex, body mass index (BMI) and height were collected. 
Nursing forms included parameters that were filled out by nursing during the 
colonoscopy procedure. Please see attached nursing form in the appendix for more 
information. Patient stickers were placed on the patient chart to help identify the data so 
that charts couldbe accessed for adenoma and polyp detection rates. Data collected 
weretransferred to a data collection sheet which was de-identified with linking 
information present in a key file. This file is planned to be destroyed along with patient 
forms once the publication plan is finalized. Institutional review board (IRB) was 
reviewed by the Saint Luke’s IRB and was sent for further review by Schulman IRB 
which is an IRB based in Ohio which oversees studies at Saint Luke’s which involve an 
intervention. IRB approval was obtained from Schulman. The quality committee and 
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Saint Luke’s North and Saint Luke’s South also conducted a separate review of the study 
and approved it before implementation.  
Study Population 
 Patients undergoing colonoscopy for various procedures were enrolled for the 
study. 
Inclusion Criteria: 
Adults aged 50 and older undergoing a colonoscopy procedure at St. Luke’s Hospital 
of Kansas City Missouri Plaza location, Saint Luke’s North Hospital and Saint Luke’s 
South Hospital were included. Hemodynamically stable patients who were able to 
undergo informed consent for the procedure and for the study were included. 
Exclusion Criteria: 
Patients with surgical resection of all or part of the colon were excluded as these 
patients do not have a full length of the colon and may have had their right side of the 
colon resected. Withdrawal times, looping and other factors may also be affected in these 
patients. Patients who did not agree to take part in the study were also excluded. Patients 
under the age of 50, pregnant women, patients who are not able to speak English and who 
were not able to give informed consent were excluded. Patients with an emergent 
condition requiring urgent or emergent colonoscopy were excluded as to avoid delays in 
care. Patients who were found to have inadequate prep to allow screening for colorectal 
cancerwere also excluded as adenoma detection rates have been shown to be less when 
bowel prep is inadequate.  
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Withdrawal and Termination Criteria: 
 
 If patients withdrew consent to participate in the study at any time, they were 
allowed to withdraw from the study. If the patients met any of the exclusion criteria at the 
time of enrollment or were found to meet any criteria during the procedure, for example 
poor bowel prep or previous colonic surgery that was not part of the history, their 
participation was terminated and patients were excluded.  
Measures 
Primary Predictor/Intervention 
 After informed consent was obtained, patients were randomized to either the 
group undergoing examination of the right colon for greater than or equal to 3 minutes or 
less than three minutes (withdrawal time). Withdrawal time was started after identifying 
the appendiceal orifice if terminal ileum intubation was not planned. If terminal ileum 
intubation was planned then withdrawal time was started after the intubation was 
completed or if the intubation failed. Withdrawal time of the ascending colon concluded 
after identifying the hepatic flexure. Right colon withdrawal time was the primary 
predictor. Modified withdrawal time was also calculated which took the time required for 
polypectomy into account. We only had polypectomy data for 25% of patients so we used 
this average to deduct the polypectomy time from all polypectomy. Average time 
required to remove the first ascending colon polyp was 45 seconds and time required to 
remove a second ascending colon polyp and subsequent polyps were 20 seconds each. 
Although this data is not 100% accurate, we used it as an estimate of right colon 
withdrawal time independent of time needed for polypectomy. 
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 A secondary predictor was time spent during retroflexion, if retroflexion was 
performed. Groups comprised of patients undergoing retroflexion for ≥ 30 seconds and 
were compared to retroflexion for < 30 seconds. This was at the discretion of the 
endoscopist. It was noted if the retroflexion was attempted and failed or if it was 
successful and the time spend during retroflexion was calculated. Retroflexion was not 
randomized as the practice of routine retroflexion varied among endoscopists. 
Randomization was also not ideal as, in some patients, retroflexion can be challenging 
and continued retroflexion if the lumen of the colon was not adequately seen can lead to 
no benefit and spending longer duration would have limited benefit. Barriers to 
retroflexion were also identified and were considered and assessed during data 
collection.Number of attempts made for retroflexion was also recorded. 
 Age was collected in years, sex was categorized as male or female. Body mass 
index was collected as a numerical value. American Society of Anesthesiologists (ASA) 
score was determined from 1-4 as per pre-procedure anesthesia evaluation. Race was 
defined as Caucasian, African American, Hispanic, Asian and other. History of colon 
polyps and family history of colon cancer were recorded. Smoking status was determined 
as current smoker or not a current smoker. Indication for the colonoscopy was collected. 
Bowel preparation scale was noted during the procedure according to the Boston Bowel 
Prep Scale and ranged from 1 (indicating inadequate bowel prep) to 3 (indicating 
excellent bowel prep).  
Outcome Measures 
Adenoma detection rate was the primary outcome measure. It was defined as the 
proportion of colonoscopies in which adenomas were detected, compared to all 
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colonoscopies.  Polyp detection rate was also calculated and was defined as the 
proportion of colonoscopies in which any type of polyp was removed during the exam 
compared to all colonoscopies. Adenoma detection rates were determined for each 
endoscopist and each fellow. Fellow involvement was also considered when 
analyzingadenoma detection rates.  
Other Predictors/ Independent Variables 
Quality of bowel prep was also recorded in each segment of the colon. Type of 
colonoscope (adult, pediatric or hybrid Fujinoncolonoscopes) used and looping during 
colonoscopy was also recorded. If retroflexion was attempted but failed, the endoscopist 
was asked to comment on the reason of failure with the choices being due to looping, 
narrow lumen of the colon, poor bowel prep, type of colonoscope used, technical 
difficulty or other and to specify. Utilization of pressure, total withdrawal time and time 
of day were also collected to check for an influence on the primary outcome measure. 
Data Collection Procedures 
Patients who were scheduled to undergo a colonoscopy at Saint Luke’s Hospital 
of Kansas City Missouri, Saint Luke’s North Hospital and Saint Luke’s South Hospital 
were identified by the study team by looking at the endoscopy schedule for the day. This 
information was available in paper form on the day of the procedures or electronically 
using the electronic health record. The sub investigators identified these patients, and 
patients meeting the inclusion criteria were approached by the study investigators to 
discuss the study and obtain informed consent prior to the procedure. If the patient agreed 
to participate in the study pertinent parameters were collected by the procedure nurse 
during the procedure. The nursing forms were provided to the nurses at each hospital 
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location. The forms, after being filled out, were picked up by the study investigators and 
kept at a secure location. Data from the study forms wereentered into the data collection 
sheet. Other pertinent clinical and endoscopic parameters from the electronic health 
record were collected in an excel data sheet by investigators using their personal logins.  
Data Management and Security 
The participants were assigned random study ID numbers and keythat matched 
medical record number to study number was destroyed after all data collection. De-
identified data werecollected and no patient identifying informationwascollected in the 
final data sheet to prevent potential breach of confidentiality. The data and key (during 
data collection) were stored in a secure location. Only study investigators had access to 
this data. The excel sheet and key also had password protection. De-identified data will 
be stored for 2 years while link to data will be destroyed upon completion of the 
publication requirements. 
Risks and Benefits to Patients 
There was thought to be no or minimal risk; physical, psychological, social or 
economical, to the patients except breach of confidentiality. Risks associated with 
retroflexion are extremely rare and only one reported case is available of perforation for 
this widely performed maneuver. The standard procedure time was not thought to be 
increased significantly due to the study procedures. The study participants were educated 
that the study procedures may or may not benefit them directly but may help future 
patients by investigating the research question of the study. 
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Statistical Analysis 
 
There were 250 patients included in the statistical analysis who met inclusion 
criteria. There were 135 patients randomized to the ≥ 3 minutes right colon withdrawal 
arm and 115 patients randomized to the <3 minutes right colon withdrawal arm. 
Descriptive statistics were used to describe patient demographics and other parameters 
described in the measures section. We used logistic regression to assess the differences in 
ADR between the two withdrawal groups and also between the ≥ 30 second retroflexion 
group and < 30 second retroflexiongroup. Logistic regression was also used to assess 
differences in polyp detection rates between the respective groups. Chi Square and t test 
were used to compare the two groups on categorical data and continuous data, 
respectively.All analyses were performed using SPSS, and p values of < 0.05 were 
considered statistically significant.  
Sample Size Calculation 
 Sample size estimate was done a priori. Adenoma detection rate in the proximal 
colon have been reported as 15.5% based on a large study of 2167 screening 
colonoscopies.46Proximal colon in this study was defined as cecum up to the splenic 
flexure. In our study we considered the right colon to be from cecum to hepatic flexure 
and hence not including the transverse colon and splenic flexure. We estimated the 
baseline adenoma detection rate of 10% in the right colon to be on the conservative side 
based on above data. For our sample, we considered a two tailed alpha level of 0.05 (type 
I error rate) and considered the rate of type II error to be 0.2 as is standard. Sample size 
was based on 80% power. We estimated an effect size of 15 percentage points changeand 
our required sample size was determined to be 226 patients with 113 patients in each arm. 
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CHAPTER 4 
RESULTS 
 
Characteristics of the Study Population 
 A total of 269 patients were enrolled and250 patients were included in the 
analysis after patients meeting exclusioncriteria were excluded. Mean age of the patients 
was 60.5 years (SD 8.5 years). 52% of patients were females and 47.6% were male. 
75.8% of patients were white, 20% were African American,1% Hispanic and 1% 
Asian.Mean BMI was 30.5 (SD 6.7) while median ASA score was 2 (SD 0.65). Fellows 
were involved in 83 colonoscopies (31%). Indication for 70% of the procedures was 
screening for colorectal cancer. There were no significant differences between the < 3 
minute withdrawal groups and ≥ 3 minutes withdrawal group when considering age, sex, 
race, BMI, ASA score, family history of colon cancer or indications (Table 2 and Table 
3, page 32 and 33 respectively).  
Results: Primary Outcome 
There were 135 patients included in the < 3 minute right colon withdrawal group 
(RCWG) while 115 patients were included in the ≥ 3 minute RCWG.Adenoma detection 
rate in the right colon was 33% if the right colon withdrawal time was ≥ 3mins compared 
to 14% if it was < 3 mins. It was three times more likely to detect adenomas in the right 
colon inthe ≥ 3mins group compared to the < 3 min group (OR 3, p<0.001, 95% CI 1.62-
5.64). Polyp detection rate in the right colon was 49% in the  ≥ 3 minute withdrawal 
group  compared to 14% in the < 3 minute withdrawal group, and chance of finding a 
polyp on the right side was 5 times more in the ≥ 3 minute right colon group compared to 
the < 3 minute group (OR 5.1 p<0.001, 95% CI 2.84 – 9.32). 
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The adenoma detection rate in the right colon was also significantly higher when 
the modified right colon withdrawal time was used in ≥ 3mins group (33%) vs. < 3mins 
group (14%) which also showed that the ≥ 3mins group was 3 times more likely to find 
adenomas in the right colon compared to the < 3 min group (OR 3, p<0.001, 95% CI 
1.62-5.64). When considering the screening population, right colon ADR was 
significantly higher in the ≥ 3mins group (33%) vs. 14% in the < 3 mins group p=0.004). 
We also constructed a Receiver Operative Characteristic (ROC) Curvefor time cut 
off for optimal adenoma detection rate. Area under the curve was 0.73, p<0.001, 95% CI 
0.65-0.81. The cut-off point with optimal sensitivity and 1-specificity was found to be 3 
minutes and one second for adenoma detection in the right colon.  
Median time to reach cecum was 360seconds (6mins), median withdrawal time 
was 660seconds (11mins), and median right colon withdrawal time (RWT) was 165 
seconds. There were no differences between the groups in indication p=0.4, family 
history of colon cancer p=0.7 or retroflexion performed p=0.1. Overall adenoma 
detection rate in the whole colon was 50%. Average polypectomy time was 45seconds 
and 20 seconds for a second polyp in the ascending colon; this was excluded from RWT 
to generate a modified right colon withdrawal time (MRWT).A fellow was more likely to 
be involved when RWT was  ≥ 3mins (46%) vs. < 3mins (16%) p<0.001. There was no 
difference in the overall adenoma detection rate or that in the right colon based on fellow 
involvement (p=0.7). 
Secondary Outcome 
 
 Reteroflexion was performed in 101 patients (71%) for < 30 seconds and 40 
patients (29%) had retroflexion performed for ≥ 30 seconds. Adult colonoscope (12.8mm 
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diameter) was used in 82% of patients while a pediatric colonoscope (11.5mm diameter) 
was used in 18%. 
Adenoma detection rate in the right colon was 45% when retroflexion was 
performed for ≥ 30 seconds compared to 23% in the group where it was performed for < 
30 seconds (OR 2.8, p=0.01, 95% CI 1.26 – 6.0). Polyps that were seen only on 
retroflexion, which could not be seen on forward view, were significantly more likely to 
be found in the ≥ 30 second group (22%, n =8) compared to the < 30 second group (3%, 
n=1), p<0.001.  
Successful retroflexion was defined as completing the retroflexion maneuver in the 
right colon. GI fellows were successful in retroflexion in 58% of cases while attending 
physicians were successful in 74% of cases p=0.027. Retroflexion success was 90% when 
there was no looping, vs. 89% with mild and only 25% with severe looping, p<0.001. 
Retroflexion was successful in 54% of the cases with Boston bowel prep score of 2 
compared to 72% with score of 3 in the right colon p=0.005. Successful retroflexion was 
performed in 81% when no abdominal pressure was required vs. 58% with pressure 
p=0.001. Patients in whom retroflexion failed had a higher BMI (mean 31.6 vs. 29.8, 
p=0.04). ASA score (p=0.6), sex (p=0.7), race (0.9) and type of colonoscope (0.6) were 
not significantly associated with retroflexion success. Chance of success was very low 
(3%) after the second attempt of retroflexion.  
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CHAPTER 5 
 
DISCUSSION 
Adenoma detection rate is the benchmark for measuring the quality of endoscopy. 
It is inversely related to risk of interval colorectal cancer and fatal interval 
cancer.1Several previous studies have shown that the risk of missing lesions is the highest 
in the right side of the colon4,7 which could in turn lead to higher risk of interval colon 
cancer and mortality. In this study we aimed to assess the utility of a careful examination 
of the right side of the colon and its effect on adenoma detection rate. It has been shown 
previously that a longer withdrawal time can increase adenoma detection rate25,29,30 and a 
withdrawal time of 6 minutes has been shown to significantly improve adenoma 
detection.25Currently there are no guidelines to recommend an adequate right colon 
withdrawal time, and endoscopists can spend a variable fraction of the 6 minute 
withdrawal time in the right colon. In our study we found a significant increase in 
adenoma detection in the right colon when more than 3 minutes were spent for right 
colon examination. This included forward view exam as well as retroflexed exam. 
Our study showed that the < 3 minute group was 65% less likely to find adenomas 
in the right colon (OR 0.35, p<0.001, 95% CI 0.177-0.616) compared to if the right colon 
was examined for ≥ 3 minutes.The rate of retroflexion did not differ significantly 
between the < 3 minute arm and ≥ 3minute withdrawal arm. This suggests that 
retroflexion duration is independently associated with higher adenoma detection rate. We 
also analyzed a regression model to account for the interaction between a longer than 
three minute withdrawal and longer than thirty second retroflexion and adenoma 
detection rate. It showed no significant interaction p=0.9. 
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Retroflexion for more than 30 seconds significantly increased adenoma detection 
rate. However, experienced endoscopist, no looping, better bowel prep and lower BMI of 
the patient were associated with successful retroflexion. Given that absence of these 
factors can be associated with a higher rate of failed retroflexion, they may also lead to a 
lower adenoma detection rate if retroflexion is limited. 
 Experience of the endoscopist and routine use of retroflexion by the endoscopist 
were associated with higher rates of success. This is consistent with previous 
studies.32Even when retroflexion was successful, endoscopists who routinely perform 
retroflexionwere more likely to find polyps on retroflexion. This could suggest a learning 
curve with the retroflexion maneuver as well as visualization of polyps in retroflexion. It 
was also observed that the highest yield in retroflexion was when the colonoscope was 
retroflexed in the cecum and the colonoscope was withdrawn while in retroflexed 
position up to the hepatic flexure. This maneuver was most successful when torque was 
used to look behind fold just as one would in forward view. Locking the small dial on the 
colonoscope, during retroflexed withdrawal, was also helpful.  
We saw that the withdrawal time in the right colon and during the colonoscopy 
procedure as a whole was longer when fellows were involved, but interestingly this did 
not affect adenoma detection rate. In previous studies it has been shown that having a 
second observer like an experienced endoscopy nurse who has more than two years of 
experience increased adenoma detection rate.27This could be a limitation of the 
withdrawal technique of a trainee or that our sample size of having fellow involvement 
was not large enough to achieve statistical significance.  
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ADR differs only slightly when the indication for a colonoscopy is considered. 
Diagnostic colonoscopies have a lower ADR while screening and surveillance 
colonoscopies have a higher ADR with a mean difference of 2.6% between screening 
ADR and overall ADR.49 This difference has not been considered significant to alter 
ADR standards and may simplify ADR measurement.49 Therefore, we considered all 
indications including patients undergoing colonoscopy for average risk screening for 
colorectal cancer, family history of colon polyps or personal history of colon polyps. 
Patients presenting with history of abdominal pain, melena and hematochezia were also 
considered but only if they were due for a screening or a surveillance colonoscopy.  
Our study also showed that the < 3 minute group was 80% less likely to find polyps 
in the right colon (OR 0.19, p<0.001, 95% CI 0.11-0.35) compared to the ≥ 3 minutes 
group. When considering adenoma detection rate of the whole colon, the ≥ 3 minute 
withdrawal group also had a higher overall adenoma detection rate of 50%compared to 
32% in the < 3 minute group (OR 2.2 p=0.007, 95% CI 1.24- 3.81). This benefit is likely 
due to the higher adenoma detection rate of the right side of the colon as adenoma 
detection rates in the transverse colon (17.5% vs. 13.4%, p=0.37) and left colon (24% vs. 
17% p = 0.18) were comparable between ≥ 3 minute group and < 3 minute group 
respectively. 
 There were no adverse events related to the study interventions in our study. Only 
one patient had a splenic hematoma after colonoscopy. This is a patient in whom 
retroflexion was also performed. The case was discussed between the study team and the  
endoscopist. It was the opinion of the endoscopist and the conclusion of the study team 
that the complication was not related to retroflexion. The incident was reported to the 
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IRB. Spending ≥ 3 minutes in the right side of the colon was not associated with 
increased procedure-related or sedation-related adverse events. 
 It was observed that if a second attempt at retroflexion fails, subsequent attempts 
are very unlikely to be successful. We suggest that retroflexion in the ascending colon 
should not be attempted after two failed attempts as it may prolong procedure duration 
and may cause potential adverse events. The rate of retroflexion failure was not 
associated with the type of colonoscope used. 
 There were some limitations of the study. One limitation was that the 
polypectomy times were not consistently measured during the study resulting in our 
inability to calculatean accurate, modified right colon withdrawal time. This time was 
extrapolated based on the polypectomy times we had for 50 patients. Another limitation 
was that data was collected for various indications which have been shown to have a 
slightly different ADR than the screening population. However we aimed to show the 
efficacy of longer right colon withdrawal time and retroflexion in this study and both 
study arms had relatively equal number of high risk and low risk individuals. The 
endoscopists could also not be blinded and being in the longer withdrawal arm could 
have caused pressure of doing a more thorough exam. 
The ROC curve suggested a withdrawal time in the right colon of 181 seconds which 
(three minutes and one second) which was close to the three minute time we planned to 
study apriori.We suggest that at least three minutes should be spent to examine the right 
side of the colon. Retroflexion should also be performed when possible and longer 
duration of retroflexion, with withdrawal while in retroflexion to examine the proximal 
and distal ascending colon, can help increase adenoma detection rate.   
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CHAPTER 6 
CONCLUSIONS 
 Adenoma detection rate in the right colon is significantly improved when more 
than three minutes are spent examining the right side of the colon. Individuals in whom 
retroflexion was performed for longer than thirty seconds also had significantly improved 
adenoma detection rate. 
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APPENDIX A 
TABLES 
 
Table 1. TNM Staging 
 
Taken from: emedicine.medscape.com 
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Table 2.  Patient Demographics 
 
 < 3 Minute Group >/= 3 Minute 
Group 
P value 
    
Age 60.5  ± 9  60.3 ±8 0.91 
 
Sex          Male 47% 47.8% 0.95 
                Female  52.6% 52.2%  
 
Race        White 76.3% 75.2% 0.07 
                 African American 19.3% 22.1%  
 
BMI 29.6 31.2 0.69 
 
ASA Score                1 10.4% 10.6% 0.93 
                                  2 61.5% 64.6%  
                                  3 26.7% 23%  
                                  4 
 
 
1.5% 1.8%  
Colon Cancer in Family 14.2% 15.7% 0.745 
 
    
History of Colon Polyps 20% 35% 0.048 
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Table 3.  Procedure Characteristics 
 
 < 3 Minute 
Group 
>/= 3 Minute 
Group 
P value 
    
Right Colon Boston Prep Scale   2 
 
21.8% 9.5% 0.08 
                                                         3 73.6% 86.9% 
 
 
Type of Colonoscope    Standard 
 
                                          Pediatric   
89.4% 
9.8% 
 
73% 
23.4% 
 
0.005 
Looping                       None 28.9% 23.9% 0.58 
                                      Mild 31.6% 29.5%  
                                      Moderate 26.3% 35.2%  
                                      Severe 13.2% 11.4% 
 
 
Fellow Involvement 16.3% 46.1% 0.001 
 
    
Abdominal Pressure Applied 53.4% 60% 0.33 
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APPENDIX B 
 
ILLUSTRATIONS 
 
 
 
 
Figure 1.  ROC 
 Graph 1, Adenoma Detection Rate in the Right Colon
 
 
 
Graph 2, Adenoma Detection Rate in the Right Colon with 
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Retroflexion in the Right Colon 
 
 
 
Image 1: The image shows the colonoscope retroflexed in the ascending colon so that the 
back sides of the folds are seen. The black object is the colonoscope looking back on 
itself while the white marks are the markings on the colonoscope. This image illustrates 
normal mucosa of the colon. No polyps are seen. 
 
(Kushnir VM, Oh YS, Hollander T, et al. Corrigendum: Impact of Retroflexion Vs. 
Second Forward View Examination of the Right Colon on Adenoma Detection: A 
Comparison Study. Am J Gastroenterol. 2015;110(6):942. doi:10.1038/ajg.2015.144) 
 
Figure 2. Reteroflexion Image 
 
 
Fi 
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APPENDIX C. 
FORMS 
Nursing Form for Data Collection 
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Informed Consent: Page 1 
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Informed Consent Page 2 
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Informed Consent Page 3 
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Informed Consent Page 4 
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